No Data
No Data
Earnings Call Summary | Exact Sciences(EXAS.US) Q1 2025 Earnings Conference
After-market Movers: Stock Futures up Despite Apple, Amazon Falling After Earnings
12 Health Care Stocks Moving In Thursday's After-Market Session
Exact Sciences Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Sales Results and Raised Its FY25 Sales Guidance.
Exact Sciences Raises FY2025 Sales Guidance From $3.02B-3.08B to $3.07B-3.12B
Correction: Exact Sciences Q1 Adj. EPS $(0.54) Misses $(0.38) Estimate, Sales $707.00M Beat $688.64M Estimate
Hedging the Edge : Moderna, Sarepta, Biotech Stocks Sink After Top FDA Official Resigns